Recurrence of Hepatocellular Carcinoma in Hepatitis (C) Virus Related Cirrhosis Treated with Direct Acting Antiviral Therapy

Hepatocellular Carcinoma Recurrence Post Direct-Acting Antiviral and Its Relation to Time of Treating Chronic HCV Infection

Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study

RECURRENCE RATE OF HEPATOCELLULAR CARCINOMA AFTER TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH DIRECT ACTING ANTIVIRALS: RANDOMIZED CONTROLLED PHASE 3 TRIAL. PRELIMINARY RESULTS

Effect of Treating Chronic Hepatitis C Infection with Direct-Acting Antivirals on The Risk of Recurrence Hepatocellular Carcinoma

Study of Frequency of Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy in Hepatitis C Virus Patients

HCC Incidence in DAAs-Treated and Untreated Egyptian HCV-Infected Patients

Frequency of Hepatocellular Carcinoma in HCV Patients Treated with Direct-Acting Antiviral Drugs

Impact of direct-acting antiviral therapy in Egyptian patients with chronic hepatitis C and liver cirrhosis

Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis After Treatment with Direct Acting Antiviral Therapy